Identification of Serum Biomarkers for Early-Stage Knee Osteoarthritis Using Proteomics in a Murine Model of Osteoarthritis

利用蛋白质组学在小鼠骨关节炎模型中鉴定早期膝骨关节炎的血清生物标志物

阅读:2

Abstract

ObjectiveTo characterize the serum protein profiles of osteoarthritis model mice, particularly mice with early-stage osteoarthritis, using liquid chromatography-mass spectrometry (LC-MS/MS).DesignSerum and knee samples were collected from 5 control mice and 15 osteoarthritis model mice that underwent destabilization of the medial meniscus (DMM). Osteoarthritic knee samples were collected 4, 8, and 12 weeks after DMM. Knee osteoarthritis severity was scored using the Osteoarthritis Research Society International (OARSI) scoring system. All serum samples were analyzed via LC-MS/MS after removing highly abundant proteins using a ProteoMiner kit (Bio-Rad).ResultsThe average OARSI scores of the medial tibial plateau and medial femoral condyle at 8 weeks after DMM (3.40 ± 1.02 points, P = 0.03; 2.60 ± 1.71 points, P = 0.03) and 12 weeks after DMM (8.30 ± 3.12 points, P = 0.03; 4.80 ± 0.75 points, P = 0.03) were significantly higher than the corresponding values in the control group. Compared to those in the control model, 15, 35, and 56 proteins showed different expression levels at 4, 8, and 12 weeks after DMM, respectively. Differentially expressed proteins at 4 weeks after DMM included adenylate kinase, type IV intermediate filament protein, nestin, and insulin-like growth factor-binding proteins. The pathways activated at 4 weeks after DMM differed from those activated at 8 and 12 weeks after DMM.ConclusionProtein expression and activation pathways in the osteoarthritis model differed from those in the control model. Several proteins differentially expressed at 4 weeks postoperatively may be involved in the pathogenesis of osteoarthritis and serve as potential biomarkers of early-stage osteoarthritis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。